Influenza Vaccine Market Size & Share, by Type (Quadrivalent, Trivalent); Technology (Egg-based, Cell Culture); Age Group (Pediatric, Adult); Route of Administration (Injection, Nasal Spray); End-user (Hospitals, Pharmacies, Government Vaccination Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 153
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Influenza Vaccine Market

    • BioDiem Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • SANOFI
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Sinovac Biotech Ltd.
    • Serum Institute of India Pvt. Ltd.
    • Emergent BioSolutions Inc.
    • CSL Limited
    • Johnson & Johnson Services, Inc.
    • Astellas Pharma Inc.

Browse Key Market Insights with Data Illustration:


In The News

  • SANOFI acquired Transcript Bio for the purpose of deploying mRNA technology in vaccine development as well as therapeutic development. 

  • BioDiem Ltd. announced the approval of Changchun BCHT Biotechnology Co ("BCHT") as their licensee in China. A live, nasal, freeze-dried influenza vaccine was launched by BCHT in August 2020 in China.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 153
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rapid spread of influenza virus, rising COVID-19 cases, increasing healthcare spending along with incidence of chronic diseases among people are the major factors driving the growth of the influenza vaccine market.

The market is anticipated to attain a CAGR of 7 over the forecast period, i.e., 2023-2035.

Low vaccination awareness in developing countries and complex process in development of vaccines are the challenges affecting the market growth

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Gamma Vaccines Pty Ltd, GlaxoSmithKline plc, Sanofi-aventis Groupe, Sinovac Biotech Ltd., Serum Institute of India Pvt. Ltd., Emergent BioSolutions Inc., CSL Limited, Johnson & Johnson Services, Inc. and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, technology, age group, route of administration, end user, and by region.

The pediatric segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying